Skip to main content
Premium Trial:

Request an Annual Quote

Hurel Raises $9.2M in Series A Equity Round

NEW YORK (GenomeWeb News) – Bioanalytical tools company Hurel raised $9.2 million in a Series A private equity financing round, the North Brunswick, NJ-based company said today.

Proceeds from the round will go toward the commercial launch of Hurel's products, R&D work directed at its technologies and future products, and general corporate purposes, it said. Spring Mountain Capital led the round and was joined by undisclosed private investor entities.

Hurel provides artificial tissue constructs and microfluidic cell-based assay platforms that aid in predicting the reliability and efficiency of pre-clinical drug development. Its technology is based on microfluidic devices and cell cultures "that elevate the metabolic competency and endurance of cells cultured in vitro," and which simulate pharmacokinetic interactions among tissues and organs, according to the company's website.

Hurel CEO Robert Freedman said in a statement that the Series A financing will "enable us to fully execute our business plans and make a direct impact in the marketplace.

"Hurel's suite of artificial tissue and microfluidic products, which are based on cultures of actual, living cells, are aimed at transforming the way pre-clinical drug discovery is conducted, reducing drug-makers' and regulators' reliance on problematic animal tests, and improving the success rate of drug candidates that advance to clinical trials," he continued.

The Scan

Not Yet a Permanent One

NPR says the lack of a permanent Food and Drug Administration commissioner has "flummoxed" public health officials.

Unfair Targeting

Technology Review writes that a new report says the US has been unfairly targeting Chinese and Chinese-American individuals in economic espionage cases.

Limited Rapid Testing

The New York Times wonders why rapid tests for COVID-19 are not widely available in the US.

Genome Research Papers on IPAFinder, Structural Variant Expression Effects, Single-Cell RNA-Seq Markers

In Genome Research this week: IPAFinder method to detect intronic polyadenylation, influence of structural variants on gene expression, and more.